218 related articles for article (PubMed ID: 36140218)
1. Intrathecal Injection of the Secretome from ALS Motor Neurons Regulated for miR-124 Expression Prevents Disease Outcomes in SOD1-G93A Mice.
Barbosa M; Santos M; de Sousa N; Duarte-Silva S; Vaz AR; Salgado AJ; Brites D
Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140218
[TBL] [Abstract][Full Text] [Related]
2. Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons.
Barbosa M; Gomes C; Sequeira C; Gonçalves-Ribeiro J; Pina CC; Carvalho LA; Moreira R; Vaz SH; Vaz AR; Brites D
Front Cell Dev Biol; 2021; 9():634355. PubMed ID: 33968923
[TBL] [Abstract][Full Text] [Related]
3. Exosomes from NSC-34 Cells Transfected with hSOD1-G93A Are Enriched in miR-124 and Drive Alterations in Microglia Phenotype.
Pinto S; Cunha C; Barbosa M; Vaz AR; Brites D
Front Neurosci; 2017; 11():273. PubMed ID: 28567000
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-124 in Motor Neurons Plays a Key Role in ALS Pathological Processes.
Vaz AR; Vizinha D; Morais H; Colaço AR; Loch-Neckel G; Barbosa M; Brites D
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200161
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes.
Gomes C; Sequeira C; Likhite S; Dennys CN; Kolb SJ; Shaw PJ; Vaz AR; Kaspar BK; Meyer K; Brites D
Cells; 2022 Apr; 11(7):. PubMed ID: 35406750
[TBL] [Abstract][Full Text] [Related]
6. Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model.
Gomes C; Cunha C; Nascimento F; Ribeiro JA; Vaz AR; Brites D
Mol Neurobiol; 2019 Mar; 56(3):2137-2158. PubMed ID: 29995256
[TBL] [Abstract][Full Text] [Related]
7. Sarm1 knockout modifies biomarkers of neurodegeneration and spinal cord circuitry but not disease progression in the mSOD1
Collins JM; Atkinson RAK; Matthews LM; Murray IC; Perry SE; King AE
Neurobiol Dis; 2022 Oct; 172():105821. PubMed ID: 35863521
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte regional diversity in ALS includes distinct aberrant phenotypes with common and causal pathological processes.
Gomes C; Sequeira C; Barbosa M; Cunha C; Vaz AR; Brites D
Exp Cell Res; 2020 Oct; 395(2):112209. PubMed ID: 32739211
[TBL] [Abstract][Full Text] [Related]
9. Bisperoxovanadium promotes motor neuron survival and neuromuscular innervation in amyotrophic lateral sclerosis.
Wang J; Tierney L; Mann R; Lonsway T; Walker CL
Mol Brain; 2021 Oct; 14(1):155. PubMed ID: 34635126
[TBL] [Abstract][Full Text] [Related]
10. C-Boutons and Their Influence on Amyotrophic Lateral Sclerosis Disease Progression.
Wells TL; Myles JR; Akay T
J Neurosci; 2021 Sep; 41(38):8088-8101. PubMed ID: 34380764
[TBL] [Abstract][Full Text] [Related]
11. Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis.
Tada S; Okuno T; Yasui T; Nakatsuji Y; Sugimoto T; Kikutani H; Sakoda S
J Neuroinflammation; 2011 Feb; 8():19. PubMed ID: 21345177
[TBL] [Abstract][Full Text] [Related]
12. Mir-17∼92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration.
Tung YT; Peng KC; Chen YC; Yen YP; Chang M; Thams S; Chen JA
Cell Stem Cell; 2019 Aug; 25(2):193-209.e7. PubMed ID: 31155482
[TBL] [Abstract][Full Text] [Related]
13. Interfering with lysophosphatidic acid receptor edg2/lpa
Gento-Caro Á; Vilches-Herrando E; García-Morales V; Portillo F; Rodríguez-Bey G; González-Forero D; Moreno-López B
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1004-1018. PubMed ID: 33508894
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.
Martin LJ
Rev Neurosci; 2007; 18(2):115-36. PubMed ID: 17593875
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
16. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
17. Hyperexcitability in synaptic and firing activities of spinal motoneurons in an adult mouse model of amyotrophic lateral sclerosis.
Jiang MC; Adimula A; Birch D; Heckman CJ
Neuroscience; 2017 Oct; 362():33-46. PubMed ID: 28844763
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the endogenous TrkB.T1 receptor isoform restores the number of hippocampal CA1 parvalbumin-positive neurons and rescues long-term potentiation in pre-symptomatic mSOD1(G93A) ALS mice.
Quarta E; Fulgenzi G; Bravi R; Cohen EJ; Yanpallewar S; Tessarollo L; Minciacchi D
Mol Cell Neurosci; 2018 Jun; 89():33-41. PubMed ID: 29580900
[TBL] [Abstract][Full Text] [Related]
19. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis.
Almad AA; Doreswamy A; Gross SK; Richard JP; Huo Y; Haughey N; Maragakis NJ
Glia; 2016 Jul; 64(7):1154-69. PubMed ID: 27083773
[TBL] [Abstract][Full Text] [Related]
20. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Gento-Caro Á; Vilches-Herrando E; Portillo F; González-Forero D; Moreno-López B
Brain Pathol; 2022 May; 32(3):e13022. PubMed ID: 34585475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
